Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer
Clinical trial NCT02947685 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02947685
- Sponsor
- Alliance Foundation Trials, LLC.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-21
- Primary completion
- 2024-10-15
- Enrollment
- 518
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.